AstraZeneca is a leading pharmaceutical company focused on transforming cancer care. The Regional Study Budget Developer is responsible for developing and managing country and site level study budgets, ensuring compliance with Fair Market Value standards and regulatory requirements while providing expertise in clinical research budgeting.
Translate global study budgets into detailed country and site level budgets that comply with internal policies and external regulations in assigned regions and countries
Assign CPT codes for all study activities using the FMV tool, ensuring accurate and compliant cost allocation
Identify general site costs and other invoiceable items that must be included in country budgets, capturing the full financial impact of each study
Oversee and coordinate site budget partner concerns, resolving issues and supporting negotiations as needed
Monitor and analyse industry trends to inform budget assumptions and maintain competitive, compliant costings
Provide expert guidance and technical support during budget development, including assessing protocol amendments and determining when budget updates are required
Stay informed about assigned therapeutic areas and key studies to ensure budgets reflect current scientific and operational realities
Ensure adherence to AstraZeneca’s Code of Conduct and all relevant policies, collaborating with the Global Budget Developer to finalise country budget templates
Track budget progress and maintain accurate documentation of country and site specific costs, justifications, issues, and amendments
Train and mentor new team members in budget development methodologies, tools, and standards
Support process improvements, knowledge sharing, and best practice adoption across teams to enhance budget quality and efficiency
Assist with internal and external audit activities by providing clear documentation and expert input on study budgets
Qualification
Required
Bachelor's degree in related field, preferably in life science, finance, or related field
2-4 years of experience in clinical study budget development or related roles within the pharmaceutical industry
Strong understanding of clinical operations (including study design and awareness of specific site costs associated with clinical studies)
Knowledge of compliance requirements and industry regulations guidelines in assigned regions/countries
Familiarity with international guidelines ICH-GCP; basic knowledge of GMP/GDP
Strong analytical skills with the ability to interpret complex protocols
Ability to collaborate effectively in a remote environment with various internal stakeholders
Detail-oriented with excellent time-management skills, capable of managing multiple tasks with conflicting deadlines
Flexibility to adapt to changes in study design, protocol amendments, and unexpected challenges which may arise
Good communication and interpersonal skills
Experience with FMV tool(s)
Preferred
Knowledge of therapeutic areas relevant to AstraZeneca's portfolio
Comprehensive knowledge of medical/CPT coding (procedures and non-procedures) across therapeutic areas
Ability to manage change with a positive approach for self, team, and the business, viewing change as an opportunity to improve performance and add value
Track record of identifying and championing more efficient and effective methods or processes for delivering quality clinical trials with optimised budgets and timelines
Good cultural awareness and sensitivity when working across multiple countries and regions
Ability to understand the impact of technology on projects, using and developing computer skills while making appropriate use of systems and software in an e-enabled environment
Benefits
Annual Variable Pay Bonus/Short Term Incentive opportunity
Eligibility to participate in our equity-based long-term incentive program (if applicable to role)
Competitive Flex Benefits & Retirement Savings Program
4 weeks’ paid vacation
Annual Personal Days
Contract Benefits Program
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
